Reviewing Humana (NYSE:HUM) and Leap Technology (OTCMKTS:LPTC)

Humana (NYSE:HUM) and Leap Technology (OTCMKTS:LPTC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.

Analyst Recommendations

This is a summary of current ratings for Humana and Leap Technology, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	0	16	7	0	2.30
Leap Technology	0	0	0	0	0.00

Humana currently has a consensus target price of $281.4286, indicating a potential downside of 2.99%. Given Leap Technology’s higher possible upside, analysts plainly believe Leap Technology is more favorable than Humana.

Insider & Institutional Ownership

92.4% of Humana shares are owned by institutional investors. 0.4% of Humana shares are owned by insiders. Comparatively, 1.1% of Leap Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Humana and Leap Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Humana	1.28%	13.67%	4.85%
Leap Technology	N/A	N/A	N/A

Valuation & Earnings

This table compares Humana and Leap Technology”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$117.76 billion	0.30	$1.21 billion	$13.03	22.26
Leap Technology	N/A	N/A	N/A	N/A	N/A

Humana has higher revenue and earnings than Leap Technology.

Summary

Humana beats Leap Technology on 7 of the 9 factors compared between the two stocks.

About Humana

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

About Leap Technology

Le@P Technology, Inc. does not have significant operations. The company plans to pursue acquisition, joint venture, and investment opportunities primarily in the areas of health care technology, and products and services, as well as life sciences. Previously, it was involved in leasing a real property. Le@P Technology, Inc. was founded in 1997 and is based in Fort Lauderdale, Florida.